Collplant Biotechnologies Ltd current report, Q2 FY2019

CollPlant Holdings Ltd. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by CollPlant Holdings Ltd. (also referred to as CollPlant Biotechnologies Ltd.) for the month of June 2019. The filing reports on the outcome of an Extraordinary General Meeting of Shareholders convened on June 6, 2019.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance report regarding shareholder voting results and does not contain financial statements or performance data.

Material Changes

The material event reported is the successful approval of eight proposals by the Company's shareholders at the Extraordinary General Meeting. These proposals were previously detailed in the Notice and Proxy Statement filed on May 1, 2019. All proposals were approved in accordance with the required majority.

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to confirming the procedural outcome of the shareholder vote.

Key Facts for Investor Verification

  • Shareholders approved all eight proposals presented at the June 6, 2019, Extraordinary General Meeting.
  • Details of the approved proposals are located in the Notice and Proxy Statement filed on May 1, 2019 (Exhibit 99.1).
  • The filing does not include updated financial results or operational metrics for the period.